Does antegrade blood cardioplegia alone provide adequate myocardial protection in patients with left main stem disease?  by Onorati, Francesco et al.
Does antegrade blood cardioplegia alone provide adequate
myocardial protection in patients with left main stem
disease?
Francesco Onorati, MD
Attilio Renzulli, MD, FECTS
Marisa De Feo, MD
Giuseppe Santarpino, MD
Rosario Gregorio, MD
Andrea Biondi, MD
Flavio Cerasuolo, MD
Maurizio Cotrufo, MD, FECTS
Dr Onorati
Background: The optimum route for cardioplegia administration in patients with
severe coronary disease is still under debate. This study compared clinical, echo-
cardiographic, and biochemical results in patients with left main stem disease treated
with 2 different strategies of myocardial protection.
Methods: Between March 2000 and November 2002, 148 consecutive patients with
left main stem disease undergoing coronary artery bypass grafting were divided into
2 groups according to the route of cardioplegia delivery: antegrade in 87 patients
(group A) or antegrade followed by retrograde in 61 patients (group B). Electro-
cardiography, troponin I, MB-creatine kinase, and MB-creatine kinase mass were
performed at 12, 24, 48, and 72 hours postoperatively. Echocardiography was
performed preoperatively and before hospital discharge. Data were stratified in
subgroups of patients with the following associated risk factors: left ventricular
hypertrophy, diabetes, and right coronary stenosis.
Results: Groups were homogeneous in preoperative and intraoperative variables,
apart from the higher incidence of unstable angina and severity of left main stem
disease in group B. Hospital deaths, intensive therapy unit and hospital stay,
perioperative acute myocardial infarction, and intraaortic balloon pump support
were similar in both groups. Postoperative recovery of left ventricle ejection fraction
and wall motion score index did not differ between the 2 groups. However,
postoperative atrial fibrillation was higher in group A (P  .015), especially in
patients with diabetes (P  .0001). Troponin I was significantly higher in group A
from postoperative hours 12 to 72 (P  .01), and the same pattern was observed in
patients with diabetes (P  .001), critical right coronary stenosis (P  .001), and
left ventricle hypertrophy (P  .001).
Conclusion: The combined route of intermittent blood cardioplegia allows better
results in left main stem disease. Such data are confirmed even in risk subgroups.
Although Lillehei and associates1 introduced coronary sinus perfu-sion into clinical use in 1956, it faded from clinical practice untilBuckberg2 introduced retroplegia into clinical practice, demon-strating that the efficacy of oxygenated blood cardioplegia isdependent on its complete and uniform distribution to the micro-vasculature of the heart. Progresses in the technique of myocardial
protection showed that continuous warm cardioplegia could resuscitate the ischemic
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myocardium, which is not possible with cold cardioplegia.3
In the last decade, myocardial protection with intermittent
warm hyperkalemia blood cardioplegia has become a grow-
ing practice in cardiac surgery.4
Nevertheless, the preferential route of delivery of cardio-
plegia for myocardial protection in patients with severe
coronary artery disease is still under debate. Although many
cardiac surgeons suggest routinely the retrograde route of
administration,5,6 others prefer the antegrade route.7,8 Such
controversies arise from the large amount of clinical, bio-
chemical, and histologic studies that have been performed
during the last 2 decades. Several authors9 argue that ex-
perimental studies on retrograde cardioplegia performed in
dogs may be of questionable relevance because of the
differences in canine anatomy with predominant venous
drainage by way of thebesian veins rather than the coronary
sinus. Moreover, other investigators10 have found a larger
number of thebesian veins and other venous channels in
patients with a coronary atherosclerotic obstruction, and
70% of such patients can be shown to have increased
coronary arteriovenous shunts.
Moreover, adequacy of myocardial protection may vary
according to many other factors such as severity of coronary
disease, composition, viscosity and temperature of the car-
dioplegic solution, time of infusion, and associated comor-
bidities (diabetes and left ventricular hypertrophy).
In addition to such findings, it has to be considered that
modern on-pump myocardial revascularization in routine
cases rarely requires more than 60 minutes of aortic cross-
clamping; therefore, differences in clinical end points are
difficult to ascertain.11
Recently, troponin (Tn) I was shown to be a specific
marker of cardiac damage with a higher specificity and a
wider diagnostic window compared with creatine kinase
(CK)-MB measurements.12 Therefore, it is widely accepted
that TnI should be able to detect even minor differences of
myocardial ischemia.
This study evaluated the differences between 2 delivery
routes of hyperkalemic intermittent warm blood cardiople-
gia in patients undergoing coronary artery bypass grafting
(CABG) for left main stem disease.
Materials and Methods
Patient Selection
In January 2000, a postoperative protocol to evaluate perioperative
myocardial damage after CABG was started. Twelve-lead electro-
cardiography (ECG), color Doppler echocardiography, and bio-
chemical markers of myocardial damage such as MB-CK, MB-CK
mass, and TnI were used to assess damage preoperatively and
postoperatively.
Exclusion criteria were associated cardiac disease (valvular,
aortic disease, and congenital pathology) or severe associated
comorbidities (renal and hepatic failure, cancer, and autoimmune
disease).
Between March 2000 and November 2002, 1610 consecutive
patients undergoing first-time isolated CABG were enrolled in the
study. Of these patients, 148 had a significant (50%) left main
stem disease and were divided into 2 groups (after informed
consent was obtained) according to the route of cardioplegia
administration. The study protocol was approved by the institu-
tional review board.
The following criteria were used for definition of comorbidi-
ties: hypertension (systolic blood pressure 140 mm Hg, diastolic
blood pressure  90 mm Hg, or ongoing treatment with any
antihypertensive medication); insulin-dependent and non-insulin-
dependent diabetes (fasting blood glucose levels  140 mg/dL on
at least 2 occasions or use of antidiabetic medication [oral drugs or
insulin]; and right coronary artery stenosis (critical [75%] ob-
struction in a right dominant coronary artery).
Anesthetic Technique
Anesthesia consisted of propofol infusion at 3 mg · kg · h and
fentanyl administration at 0.10 mg every 20 minutes. Neuromus-
cular blockade was achieved with pancuronium bromide. Alfa-
adrenergic drugs were used as required to maintain mean systemic
pressure between 50 and 60 mm Hg.
Surgical Technique
Surgery was always performed by the same group of surgeons (no.
4). Assignment criteria to each surgeon were completely random,
and the choice of myocardial protection technique was left to the
surgeon. However, the combined route was more often preferred
when unstable angina and left main stem stenosis greater than 90%
were observed.
In all patients, CABG was performed through a median ster-
notomy. The left internal thoracic artery was harvested as a pedicle
and anastomosed to the left anterior descending artery in all cases.
The radial artery was always anastomosed to the ascending aorta.
The right internal thoracic artery was harvested as a pedicle and
never used as a free graft.
Heparin was administered at a dose of 300 IU/kg to achieve a
target activated clotting time of 480 seconds or greater. Blood
recovery with an autotransfusion device (Autotrans Dideco; Mi-
randola, Modena, Italy) was performed intraoperatively in all
cases. A level of hemoglobin less than 8 g/dL indicated blood
transfusion.
The standard cardiopulmonary bypass circuit was used: a
Dideco tubing set, which included a 40-m filter, a Stockert roller
pump (Stockert Instrumente, Munich, Germany), and a hollow
fiber membrane oxygenator (Monolyth; Sorin Biomedica, Salug-
gia, Italy). The extracorporeal circuit was primed with 1000 mL of
Ringer’s lactate and 40 mg of heparin. Nonpulsatile flow with an
output of 2.4 L · m2 · min was used. Systemic temperature was
kept between 32°C and 34°C. Proximal anastomoses were always
performed with aortic partial clamping.
Myocardial Protection
Myocardial protection was always achieved with intermittent hy-
perkalemic blood cardioplegia as reported by Calafiore and col-
leagues.4
In 87 patients (group A), cardioplegia was administered
through the aortic root every 20 minutes (500 mL of blood con-
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taining 20 mEq/L of K delivered into the aortic root at a pressure
of 70 mm Hg and a temperature of 34°C for 3 minutes). In 61
patients (group B), after cardiac arrest was achieved with an
antegrade infusion according to the previously mentioned protocol,
the aortic root was vented and retrograde delivery of cardioplegia
was commenced through an auto-inflating coronary sinus cannula
at a flow rate of 200 mL/min for 2 minutes. Coronary sinus was
cannulated with the blind technique through the lower portion of
the right atrium, according to the method proposed by Gundry and
colleagues.13 Coronary sinus pressure was monitored continuously
by a separate pressure-monitoring line and maintained at less than
30 mm Hg throughout the procedure. The adequacy of cannula
positioning was confirmed by observing distension of the posterior
interventricular vein, maintaining coronary sinus pressure, and
palpating the coronary sinus cannula. In group B, repeated doses
lasting 3 minutes were administered every 20 minutes always by
retrograde route alone. Warm reperfusion was never used in the
present study.
ECG
Twelve-lead ECG was performed preoperatively, at admission in
the intensive therapy unit, and then daily thereafter until hospital
discharge. All patients underwent continuous ECG monitoring at
least for the first 48 hours postoperatively. The incidence of
dysrhythmias was recorded with transient ischemic events (ST
segment elevation  1 mm). ECG diagnostic criteria for periop-
erative myocardial infarction (MI) were new Q waves greater than
0.04 ms or a reduction in R waves greater than 25% in at least 2
leads or both.
Biochemical Analysis
Blood samples were always collected from the central venous line;
the tip of the cannula was located in the lower part of the right
atrium as confirmed by chest radiography postoperative control.
Determination of blood concentration of cardiac TnI, MB-CK,
and MB-CK mass was conducted preoperatively before anesthetic
induction and postoperatively at 12, 24, 48, and 72 hours.
The assays were performed using diagnostic kits provided by
Beckman Coulter (Fullerton, Calif) for TnI (Access Immunoassay
System, AccuTnI), MB-CK mass (Access Immunoassay System,
MB-CK), and MB-CK (Synchron CX System).
Echocardiography
All studies were performed using a transthoracic Acuson Sequoia
C256 echocardiography system (Acuson Corporation, Mountain
View, Calif) with probe 3V2C, always by the same 2 physicians in
a blind manner, preoperatively, at the time of hospital admission,
and before hospital discharge. Left ventricle ejection fraction (EF),
wall motion score index (WMSI), and indexed left ventricular
mass were recorded. A value of indexed left ventricular mass
greater than 125 g/m2 indicated left ventricular hypertrophy.
Definition of Perioperative MI
Perioperative acute MI was defined according to the previously
mentioned ECG criteria, new akinetic segment at echocardiogra-
phy, and detection of peak TnI greater than 3.7 g/L or TnI
concentration greater than 3.1 g/L at hour 12, as determined by
Mair and colleagues.14
Inotropic Support
Inotropic support was defined as low dose when enoximone or
dobutamine was administered at a dosage less than 5 g · kg · min,
as medium dose when dobutamine or dopamine was administered
at dosages between 5 and 10 g · kg · min for more than 6 hours
postoperatively, and as high dose when epinephrine was added to
dobutamine or dopamine administered at a dosage greater than
10 g · kg · min.
Statistical Analysis
Statistical analysis was performed with the SPSS program for
Windows, version 10.1 (SPSS Inc, Chicago, Ill). Continuous vari-
ables are presented as mean  SD, and categoric variables are
presented as absolute numbers or percentage. Data were checked
for normality before statistical analysis. Normally distributed con-
tinuous variables were compared using the unpaired t test, whereas
the Mann-Whitney U test was used for those variables that were
not normally distributed. Categoric variables were analyzed using
the 2 square test or Fischer’s exact test.
Study Limitations
An ideal comparison between 2 treatments should be performed on
the basis of a prospective randomized study. Although the study
was prospectively designed, no real randomization was performed.
CABG procedures were always performed by the same group of
surgeons (no. 4), but the option to add retrograde cardioplegia was
the surgeon’s choice.
Moreover, the 2 groups were not homogeneous for severity of
left main lesion and incidence of unstable angina. Such differ-
ences, however, cannot be considered as bias because patients with
the worst coronary lesions and clinical conditions were preferen-
tially treated with the combined route.
Finally, randomized study in a single-center experience may
carry some bias, especially concerning the techniques of myocar-
dial revascularization.
Results
Groups proved homogeneous in most of the preoperative
characteristics, as reported in Table 1. Intraoperative char-
acteristics are shown in Table 2.
There were no differences between the 2 groups in terms
of intensive care or hospital stay (Table 2). There were 3
hospital deaths, 2 in group A (pneumonia and multi-organ
failure) and 1 in group B (mesenteric infarction) (P .402).
Two patients in each group developed postoperative MI
(P  .547).
Two patients in group A and 1 patient in group B
required postoperative intra-aortic balloon pump (P 
.402); however, enzymatic release, ECG pattern, and echo-
cardiographic evaluation did not show any data indicative of
perioperative MI. Mechanical assistance was discontinued
in all cases within 48 hours after the operation.
The number of patients who did not require any inotropic
support at all was statistically higher in the group with
combined cardioplegia; furthermore, there was no differ-
ence between the 2 groups in regard to the number of
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patients requiring medium- and low-dose inotropic support.
More patients who underwent antegrade cardioplegia deliv-
ery alone required a high dose of inotropic support (Table
2).
There were no patients demonstrating postoperative
atrioventricular block. On the contrary, the prevalence of
postoperative paroxysmal atrial fibrillation was higher in
group A, as shown in Table 2. However, all patients were
discharged with normal sinus rhythm, and no complications
of atrial fibrillation were recorded during the hospital stay.
In subgroups of patients with diabetes, postoperative atrial
fibrillation was recorded more frequently in patients treated
with antegrade cardioplegia alone (group A 19/29, 65.5% vs
group B 5/32, 15.6%; P  .0001).
The biochemical results are reported in Figure 1. Enzyme
assays showed statistically higher values in patients who
underwent antegrade cardioplegia alone in terms of TnI
starting from postoperative hours 12 to 72 (hour 12: 1.83 
0.81 ng/mL vs 1.17 0.68; hour 24: 1.66 1.32 vs 0.92
0.58; hour 48: 1.45  1.59 vs 0.77  0.72; hour 72: 1.15 
1.65 vs 0.50  0.64). This was confirmed by MB-CK mass
at hour 12 (27.1  47.5 ng/mL vs 12.7  22.3); however,
such enzyme release never fulfilled the criteria of perioper-
ative MI.13
By stratifying the population in subgroups according to
some preoperative risk factors (Figure 2), the TnI pattern
proved statistically higher in antegrade cardioplegia alone at
12, 24, 48, and 72 hours postsurgery in patients with dia-
betes (hour 12: 2.3  0.5 ng/mL vs 1.0  0.5; hour 24:
2.2  1.7 vs 0.7  0.4, hour 48: 1.9  1.1 vs 0.5  0.4;
hour 72: 1.9  2.3 vs 0.2  0.2). The same pattern of TnI
course was also demonstrated in subsets of patients with
critical right coronary stenosis (hour 12: 2.3 0.3 ng/mL vs
1.1  0.7; hour 24: 2.0  1.0 vs 0.8  0.6; hour 48: 2.2 
TABLE 1. Preoperative characteristics
Group A Group B P
No. of patients 87 61
Mean age 58.9  9.9 58.6  15.1 .884
Sex (M/F) 74/13 54/7 .164
Euroscore 3.6  2.2 4.0  2.0 .228
Diabetes 29 26 .07
Hypertension 63 41 .114
Unstable angina 45 (51.7%) 44 (72.1%) .006
AMI  4 weeks 20 19 .08
Left main stem 50%-75% 72 (82.7%) 35 (57.4%) .0001
Left main stem 75% 15 (17.2%) 26 (42.6%) .001
Right coronary stenosis 32 22 .137
EF 40% 25 18 .145
Wall motion score index 1.43  0.36 1.63  0.26 .0001
Preoperative EF 51.5  8.7 51.2  10.1 .098
Indexed left ventricular
mass 125 g/m2
30 25 .099
EF, Ejection fraction; AMI, acute myocardial infarction.
TABLE 2. Intraoperative characteristics.
Group A Group B P
Aortic crossclamp time 39.2 14.3 41.6 11.9 .294
Cardiopulmonary bypass time 72.9 25.3 75.1 18.1 .559
No. of diseased vessels 3.2 0.9 3.2 0.8 .422
No. of grafts 3.3 0.8 3.3 0.9 .855
Complete arterial revascularization 12 (13.8%) 15 (24.6%) .129
No. of left ventricle defibrillation 4 (4.5%) 5 (8.2%) .287
Inotropes low dose 31 (35.7%) 23 (37.7%) .465
Inotropes medium dose 21 (24.1%) 8 (13.1%) .07
Inotropes high dose 10 (11.5%) 0 .004
No inotropes 25 (28.7%) 30 (49.2%) .009
Intra-aortic balloon pump 2 (2.3%) 1 (1.6%) .402
Perioperative Q AMI 2 (2.3%) 2 (3.2%) .547
Atrial fibrillation 30 (34.5%) 10 (16.4%) .015
Transient atrioventricular block - - -
Intensive therapy unit stay 2.9 1.3 3.3 2.4 .144
In-hospital stay 8.7 1.9 8.2 3.0 .267
Postoperative EF 54.3 6.8 54.7 8.2 .291
Postoperative wall motion
score index
1.15 1.18 1.13 0.12 .202
Figure 1. Assay of biochemical markers in overall population.
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1.9 vs 0.6  0.6; hour 72: 1.8  2.2 vs 0.4  0.6) and in
patients with left ventricle hypertrophy (hour 12: 1.8  0.7
ng/mL vs 1.1  0.6; hour 24: 1.7  1.2 vs 0.9  0.6; hour
48: 1.7 2.1 vs 0.7 0.5; hour 72: 1.5 2.1 vs 0.5 0.6).
In regard to echocardiographic data, both types of myo-
cardial protection demonstrated a mild improvement in left
ventricle EF (group A: preoperative EF, 51.5%  8.7%;
postoperative EF, 54.3%  6.8%; P  .0001; group B:
preoperative EF, 51.2%  10.1%; postoperative EF,
54.7%  8.2; P  .0001) and left ventricle WMSI (group
A: preoperative WMSI, 1.43  0.36; postoperative WMSI,
1.14 0.17; P .0001; group B: preoperative WMSI, 1.63
0.26; postoperative WMSI, 1.13  0.12; P  .0001).
Discussion
The infusion of cardioplegic solution through the aortic root
produces very quick diastolic arrest and good preservation
of myocardial function. However, when advanced coronary
disease is considered, it can result in an uneven distribution
and, consequently, delayed functional recovery.15 There-
fore, myocardial areas distal to complete coronary artery
occlusion are poorly protected by antegrade cardioplegia.
This can lead to myocardial injury and depressed postoper-
ative left ventricular function.
Experimental studies have shown that in the presence of
coronary occlusions, retrograde cardioplegia results in bet-
ter distribution, myocardial cooling, and more complete
recovery of function in the areas beyond the occlusion.16,17
However, veno-venous shunts and thebesian channels
draining into the ventricular cavity may limit retrograde
distribution of cardioplegia.3
Therefore, some authors have shown no clear advantage
in myocardial protection of retrograde versus antegrade
cardioplegia.15 Such findings, together with some draw-
backs associated with retrograde perfusion, such as myo-
cardial edema and coronary sinus rupture, caused many
investigators to support the antegrade route alone even in
patients with severe coronary artery disease.18,19
Most of the conclusions were proven for cold crystalloid
cardioplegia, in which the low viscosity of the solution may
provide adequate peripheral distribution even in critical
proximal stenoses.5
Technical problems can be circumvented by the tech-
nique of transatrial insertion of a balloon-tipped catheter
that maintains pressure in coronary sinus of less than 50 mm
Hg.13 Furthermore, blind cannulation of coronary sinus is
simple and avoids the use of bicaval cannulation and right
atriotomy.
The advantages of retrograde blood cardioplegia perfu-
sion are the establishment of aerobic arrest; protection in
areas distal to acute MI, ungraftable vessels, and acute
occlusion; and elevation of the heart rate and dissection of
coronary arteries while administering cardioplegia.20,21
Currently, crossclamp time rarely exceeds 60 minutes in
routine practice; therefore, clinical end points are difficult to
ascertain and require large series of patients.11
During the past decade, the myocardial isoforms of Tns
have been introduced in these terms, overcoming the bio-
chemical limitations of CK-MB and myoglobin measure-
ments. On the other hand, the detection of TnI is completely
specific for myocardial damage. Cumulative data22 indicate
TnI levels are detectable 3 to 6 hours after the onset of
myocardial injury; moreover, TnI levels peak at approxi-
mately 12 to 16 hours and can remain elevated for 4 to 9
days post-acute MI. Therefore, it is widely accepted that TnI
should be able to detect even minor differences of myocar-
dial ischemia.23
Figure 2. Subgroup analysis according to risk factors.
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According to these data, postoperative TnI assay should
be considered the gold standard test in studies concerning
postoperative incidence of MI and in the assessment of the
adequacy of myocardial protection.
The results of our study, although not randomized, indi-
cate that combined delivery of blood cardioplegia shows a
significantly lower level of postoperative TnI until the
fourth postoperative day. Such biochemical findings are
further supported by a significantly lower release of MB-CK
mass at 12 hours postoperatively.
Although major clinical end points such as hospital mor-
tality, postoperative MI, intensive therapy unit and hospital
stay, and intra-aortic balloon pump support did not reach
statistically significant differences between the 2 groups, the
requirement of postoperative inotropic support was higher
in group A. The incidence of postoperative atrial fibrillation,
although not strictly a specific marker of adequate myocar-
dial protection, was higher in group A.
Right ventricular protection was very often presented as
a potential limitation of coronary sinus cardioplegia accord-
ing to whether there was flow through the capillaries or
through the extensive veno-venous collateral and into the
ventricular chambers through the thebesian veins.24 Specif-
ically, deficits in the delivery of cardioplegia to the posterior
septum and the right ventricle have been noted. In the warm
arrested state, these regional deficits could result in meta-
bolically active myocardium, with subsequent inadequate
oxygen, substrate delivery, and warm ischemia.25
Conversely, some authors26,27 have demonstrated that
retrograde cardioplegia delivery compared with antegrade
cardioplegia delivery is associated with similar right ventri-
cle performance, and that there are no differences in out-
come, hemodynamic indices, or enzyme data.
In the present study, Tn release showed lower levels in
patients with the combined route of administration even in
the subgroups of patients with proximal right coronary
stenosis, in whom antegrade delivery would not compensate
for the potential deficiencies of retrograde delivery as re-
ported by some authors.9 Therefore, the present study con-
firms that the retrograde route is the only potential route for
distal delivery of cardioplegia in patients with severe coro-
nary artery disease involving the left main and right coro-
nary arteries.
Moreover, the sub-endocardium is the most vulnerable
region of the heart to ischemia, particularly in the hypertro-
phied ventricle. Another interesting finding of our study is
the significantly lower release of TnI and MB-CK mass
even in patients with left ventricle hypertrophy. Such data
are consistent with others who showed better protection of
the hypertrophied ventricle with retrograde cardioplegia.28
Finally, the finding of a significantly lower TnI release and
incidence of postoperative atrial fibrillation in the subgroup
of diabetic patients who underwent combined delivery of
cardioplegia supports the hypothesis that patients with ex-
tensive coronary disease and impairment of coronary mi-
crocirculation (as reported in diabetes) may greatly benefit
from myocardial protection strategy. Such data are sup-
ported by the hypothesis of Buckberg and colleagues29 and
Gates and colleagues30 that retrograde blood cardioplegia
perfuses some capillaries that are not perfused by antegrade
blood cardioplegia alone.
Conclusion
The present study confirms that TnI is a good biochemical
marker to evaluate differences in strategies of myocardial
protection, whereas MB-CK and MB-CK mass can be used
only for the diagnosis of MI. In patients with left main stem
disease undergoing on-pump CABG with blood intermittent
cardioplegia, the combined route of administration allows
better results in terms of TnI release. Such results are
confirmed even in subgroups of patients with increased
ventricular mass and impaired microvascular circulation
resulting from diabetes, who generally need a higher degree
of myocardial protection.
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